Revisions to the Syphilis Surveillance Case Definitions, 2018

Similar documents
SYPHILIS (Treponema pallidum) IMMEDIATE NOTIFICATION STD PROGRAM

The Use of a Rapid Syphilis Test with Specimens from an HIV Cluster Investigation in Rural West Virginia

Syphilis Treatment Protocol

Learning Objectives. Syphilis. Lessons. Epidemiology: Disease in the U.S. Syphilis Definition. Transmission. Treponema pallidum

Syphilis Technical Instructions for Civil Surgeons

The Great Imitator Revealed: Syphilis

Lisa Villarroel, MD MPH Medical Director, Division of Public Health Preparedness Arizona Department of Health Services.

Syphilis: Management Challenges

SYPHILIS. The Great Pretender K. Amen Eguakun, MSN, APRN, AAHIVS

Sex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046)

Sexually Transmitted Diseases Treatment Guidelines, 2015

Use of Treponemal Immunoassays for Screening and Diagnosis of Syphilis

9/9/2015. Began to see a shift in 2012 Early syphilis cases more than doubled from year before

Syphilis Update. roadmap

Syphilis Update: New Presentations of an Old Disease

5/1/2017. Sexually Transmitted Diseases Burning Questions

Public/Private Partnerships: Intervening in the Spread of Syphilis

* Proposed new case definition; to be confirmed by AFHSC following analyses of data

SEXUALLY TRANSMITED DISEASES SYPHILIS ( LUES ) Dr D. Tenea Department of Dermatology University of Pretoria

Didactic Series. STD Screening & Management: Syphilis. Christian B. Ramers, MD, MPH

Syphilis Update. Dr. Bauer has no disclosures. STD Clinical Update San Diego California Prevention Training Center October 11, 2018

Syphilis in the 21 st Century: Sex, Sores, Science, and Surveillance. Syphilis in Men

Learning Objectives. Epidemiology 5/3/2013. Treponema pallidum Diagnosis, Treatment and Prevention. Anne Rompalo, MD, ScM Professor of Medicine

WHAT DO U KNOW ABOUT STIS?

2/13/ Graphic photographs or cartoons used during this presentation might be offensive to some; for this I apologize in advance.

MID 15. Syphilis. Simon Tsiouris, MD, MPH. 1. Introduction

Nothing to disclose.

Neurosyphilis as an Emerging Feature in the HIV Setting. Christina M. Marra, MD University of Washington Seattle, WA, USA

Infectious syphilis in Canada:

Sexually Transmitted Disease Treatment Tables

Syphilis among MSM: Clinical Care and Public Health Reporting

Susanne Norris Zanto, MPH, MLS (ASCP) CM, SM Montana Public Health Laboratory

Replaces: 04/13/17. / Formulated: 7/05 SYPHLIS

SYPHILIS (REPORTABLE)

Syphilis Outbreak Investigation Report

10/19/2012. Serologic Testing for Syphilis. Disclosures. Comparison of the Traditional and Reverse Screening Algorithms. Outline.

The return of infectious syphilis in Ontario

Clinical Practice Guideline with Delegation of Function

Management of Syphilis in Patients with HIV

To view an archived recording of this presentation please click the following link:

The Resurgence of Syphilis in British Columbia: Who is affected? What are the challenges? How can we improve our response?

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention

Annual Epidemiological Report

Emerging Issues in STDs and Resistance

Syphilis MID yo man is seen at an STD clinic for a painless ulcer on his penis

Clinical Practice Guideline

Medical Bacteriology Lecture 11

Profile of Syphilis. By Karley Delahoussaye

Current standards for diagnosis and treatment of syphilis: selection of some practical issues, based on the European (IUSTI) and U.S.

Professor Adrian Mindel

Current Threats of Increased Syphilis. Disclosures. Objectives

Bacteriology. Spirochetes. Three important genera: 1. Treponema 2. Borrelia 3. Leptospira. Treponema pallidum. Causes syphilis.

Medical Bacteriology- Lecture 13 Spirochaetales 1- Spirochaetaceae Treponema Borrelia 2- Leptospiraceae Leptospira

January Dear Physician:

EPIDEMIC OF SYPHILIS

NIH Public Access Author Manuscript Clin Infect Dis. Author manuscript; available in PMC 2009 October 1.

Re-emerging infections: Syphilis & Tuberculosis

Sex, Sores, Science, and Surveillance: Syphilis in the 21 st Century (U046)

Sexually transmitted infections

Another New HIV Diagnosis

Syphilis Update: Defense Against a Resurgent Foe. June 23, 2017 Stephen A. Berry, MD PhD

26. Screening for Syphilis

STDs and Hepatitis C

Syphilis in the Eye: Recognizing Acute Syphilitic Posterior Placoid Chorioretinitis

Why is syphilis important? Treponema pallidum. Attributions. Much Ado About Syphilis

Spirochetes. Treponema pallidum

CHAPTER-X SYPHILIS R.KAVITHA, M.PHARM, LECTURER, DEPARTMENT OF PHARMACEUTICS, SRM COLLEGE OF PHARMACY, SRM UNIVERSITY, KATTANKULATHUR.

A Man with a Rash and Pink Eye. STD Case Studies from the Denver Metro Health Clinic

Sexually Transmitted Diseases:

BURNING & SQUIRMING WHAT S NEW IN SEXUALLY TRANSMITTED INFECTIONS

Division of Dermatology Dr A Motau

Infectious Genital Lesions (The Sores and More)

Evaluation of Reagin Screen, a New Serological Test for Syphilis

Learning Objectives. STI Update. Case 1 6/1/2016

International Journal of Case Reports in Medicine

Int.J.Curr.Microbiol.App.Sci (2018) 7(8):

Serological screening for syphilis in HIV-infected individuals: is a non-treponemal test adequate in the era of increasing of new syphilis infections?

Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH

Frequent Screening for Syphilis as Part of HIV Monitoring Increases the Detection of Early Asymptomatic Syphilis Among HIV-Positive Homosexual Men

Sexually Transmitted Disease Prevention

S403- Update on STIs for the Generalists

Timby/Smith: Introductory Medical-Surgical Nursing, 9/e

Case Report A Case of Ocular Syphilis in a 36-Year-Old HIV-Positive Male

Syphilis Screening and Prevalence: Past, Present, Future

Blindness in. a Woman With Human Immunodeficiency Virus Infection and Syphilis

CATIE Webinar Series (Part 1) Gay Men s Health & HIV Prevention in Canada

THE REITER PROTEIN ANTIGEN TEST COMPARED WITH THE TPI AND

2019 HIV Diagnostics Conference March 27, 2019

Urogenital Tract / 3 rd year Syphilis, HPV. Dr Hamed Al-Zoubi MD, PhD Associate Prof. of Medical Microbiology

Dr Edward Coughlan. Clinical Director Christchurch Sexual Health

Direct Comparison of the Traditional and Reverse Syphilis Screening Algorithms

VDRL v/s TPHA for diagnosis of syphilis among HIV sero-reactive patients in a tertiary care hospital

Ischemic Stroke as the Initial Manifestation of Neurosyphilis in a Young Adult Patient Positive for Human Immunodeficiency Virus

Annals of Internal Medicine. 1991;114:

Various presentations of herpes simplex retinochoroiditis A case series

Downloaded from:

Syphilis Cook County Department of Public Health

Mortality Slide Series. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention

Welcome to Pathogen Group 6

Transcription:

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Revisions to the Syphilis Surveillance Case Definitions, 2018 Sarah Kidd, MD, MPH Medical Epidemiologist Division of STD Prevention Centers for Disease Control and Prevention November 16, 2017

Objectives of Syphilis Surveillance Monitor syphilis transmission (new syphilis infections) Count Primary & Secondary (or all Early) cases Monitor total syphilis diagnoses Count total (all stages) syphilis cases Monitor important clinical manifestations of syphilis E.g., neurosyphilis

Current (2014 2017) Syphilis Case Reporting Must report a case as one of the following surveillance stages Primary Secondary Early Latent Late Latent Late with Clinical Manifestations Additional variable for all cases: Neurologic involvement? Refers to Neurosyphilis case definition Answered as Yes, confirmed, Yes, probable, No, or Unknown

Why Make Revisions? Inability to track Ocular Syphilis and other important clinical manifestations Inconsistencies in the current (2014) guidance for reporting Neurologic Involvement (Neurosyphilis)

Syphilis Surveillance Case Definition Revisions 2018 Revisions related to reporting surveillance stages Revisions related to reporting clinical manifestations New clinical manifestations variables

Syphilis Case Definition Revisions for 2018: Stages Secondary Syphilis still requires BOTH reactive treponemal test AND reactive nontreponemal test, but no longer requires a titer 1:4 Nomenclature changes to remove latent from surveillance stages Early Latent Syphilis Early Non-Primary, Non-Secondary Syphilis Late Latent Syphilis Unknown Duration or Late Syphilis Late Syphilis with Clinical Manifestations omitted Report these cases as Unknown Duration or Late Syphilis Report the late clinical manifestations in the case report data with the new variables

New Clinical Manifestation Variables in 2018 Any case can be reported with one or more of the following Neurologic Manifestations (verified/likely/possible/no/unknown) Ocular Manifestations (verified/likely/possible/no/unknown) Otic Manifestations (verified/likely/possible/no/unknown) Late Clinical Manifestations (verified/likely/no/unknown) Definitions/guidance in the Position Statement

Review of Syphilis Stage Definitions

Primary Syphilis: Clinical Description A stage of infection with Treponema pallidum characterized by one or more ulcerative lesions (e.g., chancre), which might differ considerably in clinical appearance

Primary Syphilis: Case Classification Probable: A case that meets the clinical description of primary syphilis with a reactive serologic test Confirmed: A case that meets the clinical description of primary syphilis with demonstration of T. pallidum in a clinical specimen by darkfield microscopy or by PCR or equivalent direct molecular methods

Secondary Syphilis: Clinical Description A stage of infection with Treponema pallidum characterized by localized or diffuse mucocutaneous lesions (e.g., rash), often with generalized lymphadenopathy. Other signs can include mucous patches, condyloma lata, and alopecia. The primary ulcerative lesion may still be present.

Secondary Syphilis: Case Classification Probable: A case that meets the clinical description of secondary syphilis with a reactive nontreponemal test AND a reactive treponemal test Confirmed: A case that meets the clinical description of secondary syphilis with demonstration of T. pallidum in a clinical specimen by darkfield microscopy or by PCR or equivalent direct molecular methods

Early Non-Primary, Non-Secondary Syphilis: Clinical Description A stage of infection with Treponema pallidum in which initial infection has occurred within the previous 12 months, but there are no signs or symptoms of primary or secondary syphilis

Early Non-Primary, Non-Secondary Syphilis: Case Classification (Paraphrased) Probable: A case with (1) No signs/symptoms of primary or secondary syphilis AND (2) Evidence of current infection* AND (3) Evidence of having acquired infection within last 12 months (see next slide) *Evidence of current infection: No prior history of syphilis AND current reactive nontreponemal test AND current reactive treponemal test OR A prior history of syphilis with a current nontreponemal titer demonstrating a 4-fold increase from the last titer, unless there is evidence that this increase was not sustained >2 weeks

Evidence of Having Acquired Infection within Last 12 Months: Documented seroconversion of nontreponemal or treponemal test in last 12 months 4-fold increase in nontreponemal titer within last 12 months (unless increase is not sustained) History of symptoms of primary or secondary syphilis within last 12 months History of sex partner with primary, secondary, or early non-primary nonsecondary syphilis within last 12 months Sexual debut within last 12 months

Unknown Duration or Late Syphilis: Clinical Description A stage of infection with Treponema pallidum in which initial infection has occurred >12 months previously OR in which there is insufficient evidence to conclude that infection was acquired during the previous 12 months

Unknown Duration or Late Syphilis: Case Classification (Paraphrased) Probable: A case with (1) No signs/symptoms of primary or secondary syphilis AND (2) Evidence of current infection* AND (3) No evidence of having acquired infection within last 12 months *Evidence of current infection: No prior history of syphilis AND current reactive nontreponemal test AND current reactive treponemal test OR A prior history of syphilis with a current nontreponemal titer demonstrating a 4-fold increase from the last titer, unless there is evidence that this increase was not sustained >2 weeks OR Clinical signs/symptoms/labs that meet the likely or verified criteria for neurologic, ocular, otic, or late clinical manifestations

New Clinical Manifestations Variables

New Clinical Manifestations Variables Variables Neurologic Manifestations Verified, Likely, Possible, No, Unknown Ocular Manifestations Verified, Likely, Possible, No, Unknown Otic Manifestations Verified, Likely, Possible, No, Unknown Late Clinical Manifestations Verified, Likely, No, Unknown Any case can report 1 or more of these manifestations

Clinical Manifestations Variables: General Principles Must have evidence of syphilitic infection Reactive treponemal AND nontreponemal tests Must have signs/symptoms (or lesions) consistent with clinical description without other known causes for these abnormalities Clinical judgement, somewhat subjective Possible classification only requires the above 2 criteria be met Likely and Verified classifications require additional evidence

Neurologic Manifestations: Summary Serologic tests + signs/symptoms POSSIBLE Serologic tests + signs/symptoms + elevated CSF protein or WBCs LIKELY Serologic tests + signs/symptoms + positive CSF VDRL VERIFIED

Ocular Manifestations: Summary Serologic tests + signs/symptoms POSSIBLE Serologic tests + signs/symptoms + diagnosis by ophthalmologist LIKELY Serologic tests + signs/symptoms + ocular fluid positive by darkfield or PCR VERIFIED

Otic Manifestations: Summary Serologic tests + signs/symptoms POSSIBLE Serologic tests + signs/symptoms + diagnosis by otolaryngologist LIKELY Serologic tests + signs/symptoms + inner ear fluid positive by darkfield or PCR VERIFIED

LATE Clinical Manifestations: Clinical Description Inflammatory lesions of Cardiovascular system Skin Bone Other tissue Certain neurologic manifestations General paresis Tabes dorsalis

LATE Clinical Manifestations: Summary Serologic tests + characteristic lesions LIKELY Serologic tests + characteristic lesions + special stains/pcr/histology VERIFIED

LATE Clinical Manifestations: Summary Serologic tests + characteristic lesions LIKELY Serologic tests + characteristic lesions + special stains/pcr/histology VERIFIED Serologic tests + signs/symptoms of late neurosyphilis + meets criteria for likely neuro manifestations LIKELY Serologic tests + signs/symptoms of late neurosyphilis + meets criteria for verified neuro manifestations VERIFIED

Summary of Clinical Manifestations Variables Must have reactive serologic tests + signs/symptoms (or lesions)

Summary of Clinical Manifestations Variables Must have reactive serologic tests + signs/symptoms (or lesions) Things that might indicate VERIFIED CSF: VDRL positive (Neuro) Ocular fluid: detection of T. pallidum by darkfield or PCR (Ocular) Inner ear fluid: detection of T. pallidum by darkfield or PCR (Otic) Tissues/lesions: detection of T. pallidum by stains or PCR (Late)

Summary of Clinical Manifestations Variables Must have reactive serologic tests + signs/symptoms (or lesions) Things that might indicate VERIFIED CSF: VDRL positive (Neuro) Ocular fluid: detection of T. pallidum by darkfield or PCR (Ocular) Inner ear fluid: detection of T. pallidum by darkfield or PCR (Otic) Tissues/lesions: detection of T. pallidum by stains or PCR (Late) Things that might indicate LIKELY CSF: elevated protein or WBC (Neuro) Ophthalmologist diagnosis of Ocular Syphilis Otolaryngologist diagnosis of Otosyphilis Characteristic lesions of Late Syphilis

Syphilis Surveillance Case Definitions, 2018 Must report a case as one of the following surveillance stages Primary Secondary Early Non-Primary, Non-Secondary Unknown Duration or Late For Neurosyphilis, Ocular Syphilis, Otosyphilis, or Late Clinical Manifestations (Tertiary Syphilis) Report case as one of the above surveillance stages Note the clinical manifestations using the new variables

Questions and Discussion Sarah Kidd skidd@cdc.gov For more information, contact CDC 1-800-CDC-INFO (232-4636) TTY: 1-888-232-6348 www.cdc.gov The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

From CDC s 2003 Recommendations on Public Health Surveillance of Syphilis in the U.S.: Syphilis cases should be categorized and reported by stage at the time of initial examination (which is often the time of initial specimen collection), not at the time of treatment or interview.

NEUROLOGIC Manifestations: Clinical Description Infection of the central nervous system with T. pallidum, as evidenced by manifestations including syphilitic meningitis, meningovascular syphilis, general paresis, including dementia, and tabes dorsalis

Neurologic Manifestations Verified Reactive nontreponemal and treponemal serologic tests AND Clinical signs/symptoms consistent with neurosyphilis without other known causes for these clinical abnormalities AND Reactive VDRL in CSF in the absence of grossly bloody contamination of the CSF

Neurologic Manifestations - Likely Reactive nontreponemal and treponemal serologic tests AND Clinical signs/symptoms consistent with neurosyphilis without other known causes for these clinical abnormalities AND Elevated CSF protein (>50 mg/dl 2 ) or CSF leukocyte count (>5 white blood cells/cubic mm) in the absence of other known causes for these abnormalities

Neurologic Manifestations Possible Reactive nontreponemal and treponemal serologic tests AND Clinical signs/symptoms consistent with neurosyphilis without other known causes for these clinical abnormalities No CSF criteria

Neurologic Manifestations: Summary Serologic tests + signs/symptoms POSSIBLE Serologic tests + signs/symptoms + elevated CSF protein or WBCs LIKELY Serologic tests + signs/symptoms + positive CSF VDRL VERIFIED

OCULAR Manifestations: Clinical Description Infection of any eye structure with T. pallidum, as evidenced by manifestations including posterior uveitis, panuveitis, anterior uveitis, optic neuropathy, and retinal vasculitis. Ocular syphilis may lead to decreased visual acuity including permanent blindness

Ocular Manifestations Verified Reactive nontreponemal and treponemal serologic tests AND Clinical signs/symptoms consistent with ocular syphilis without other known causes for these clinical abnormalities AND Demonstration of T. pallidum in aqueous or vitreous fluid by darkfield microscopy, or by PCR or equivalent direct molecular methods

Ocular Manifestations Likely Reactive nontreponemal and treponemal serologic tests AND Clinical signs/symptoms consistent with ocular syphilis without other known causes for these clinical abnormalities AND Findings on exam by an ophthalmologist that are consistent with ocular syphilis in the absence of other known causes for these abnormalities

Ocular Manifestations Possible Reactive nontreponemal and treponemal serologic tests AND Clinical signs/symptoms consistent with ocular syphilis without other known causes for these clinical abnormalities No additional criteria

Ocular Manifestations: Summary Serologic tests + signs/symptoms POSSIBLE Serologic tests + signs/symptoms + diagnosis by ophthalmologist LIKELY Serologic tests + signs/symptoms + ocular fluid positive by darkfield or PCR VERIFIED

OTIC Manifestations: Clinical Description Infection of the cochleovestibular system with T. pallidum, as evidenced by manifestations including sensorineural hearing loss, tinnitus, and vertigo

Otic Manifestations Verified Reactive nontreponemal and treponemal serologic tests AND Clinical signs/symptoms consistent with otosyphilis without other known causes for these clinical abnormalities AND Demonstration of T. pallidum in inner ear fluid by darkfield microscopy, or by PCR or equivalent direct molecular methods

Otic Manifestations Likely Reactive nontreponemal and treponemal serologic tests AND Clinical signs/symptoms consistent with otosyphilis without other known causes for these clinical abnormalities AND Findings on exam by an otolaryngologist that are consistent with otosyphilis in the absence of other known causes for these abnormalities

Otic Manifestations Possible Reactive nontreponemal and treponemal serologic tests AND Clinical signs/symptoms consistent with otosyphilis without other known causes for these clinical abnormalities No additional criteria

Otic Manifestations: Summary Serologic tests + signs/symptoms POSSIBLE Serologic tests + signs/symptoms + diagnosis by otolaryngologist LIKELY Serologic tests + signs/symptoms + inner ear fluid positive by darkfield or PCR VERIFIED

LATE Clinical Manifestations: Clinical Description Inflammatory lesions of Cardiovascular system Skin Bone Other tissue Certain neurologic manifestations General paresis Tabes dorsalis

Late Clinical Manifestations Verified (Part 1 For Late Non-Neurologic Manifestations) Reactive nontreponemal and treponemal serologic tests AND Characteristic abnormalities or lesions of the cardiovascular system, skin, bone, or other tissue in the absence of other known causes of these abnormalities AND Demonstration of T. pallidum in late lesions by special stains or equivalent methods, or by PCR or equivalent direct molecular methods or by demonstration of pathologic changes that are consistent with T. pallidum infection on histologic examination of late lesions

Late Clinical Manifestations Verified (Part 2 For Late Neurologic Manifesations) Reactive nontreponemal and treponemal serologic tests AND Clinical signs and symptoms consistent with late neurologic manifestations of syphilis (e.g., general paresis, including dementia, or tabes dorsalis) in a case that meets the criteria for verified neurologic manifestations

Late Clinical Manifestations - Likely Reactive nontreponemal and treponemal serologic tests AND EITHER Characteristic abnormalities or lesions of the cardiovascular system, skin, bone, or other tissue in the absence of other known causes of these abnormalities OR Clinical signs and symptoms consistent with late neurologic manifestations of syphilis (e.g., general paresis, including dementia, or tabes dorsalis) in a case that meets the criteria for likely neurologic manifestations